Response

Affiliations

¹ Department of Medicine, University of Hong Kong, Hong Kong, China.
² Department of Microbiology, University of Hong Kong, Hong Kong, China. Electronic address: kyyuen@hkucc.hku.hk.

Comment

Ivan F N Hung et al. Chest. 2013 Aug.

. 2013 Aug;144(2):712-713.

doi: 10.1378/chest.13-0571.

¹ Department of Medicine, University of Hong Kong, Hong Kong, China.
² Department of Microbiology, University of Hong Kong, Hong Kong, China. Electronic address: kyyuen@hkucc.hku.hk.

No abstract available

Comment on

Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.
Hung IFN, To KKW, Lee CK, Lee KL, Yan WW, Chan K, Chan WM, Ngai CW, Law KI, Chow FL, Liu R, Lai KY, Lau CCY, Liu SH, Chan KH, Lin CK, Yuen KY. Hung IFN, et al. Chest. 2013 Aug;144(2):464-473. doi: 10.1378/chest.12-2907. Chest. 2013. PMID: 23450336 Clinical Trial.
Hyperimmune IV immunoglobulin treatment of 2009 influenza A(H1N1).
Joob B, Wiwanitkit V. Joob B, et al. Chest. 2013 Aug;144(2):712. doi: 10.1378/chest.13-0525. Chest. 2013. PMID: 23918124 No abstract available.